RxDoctor Payments Data

Daniel McGee, DO

Family Medicine · Nashville, TNNPI 1891963591

Payments from drug & device makers

$515in general payments, 2019–2025

Across 24 payments — averaging $21.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$189
  • Amgen$61
  • GSK$54
  • Novo Nordisk$52
  • Otsuka America Pharmaceutical, Inc.$44
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$33
  • plus $80 from 4 others

What the payments were for

  • Food & beverage$41581%
  • Education$10019%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$515 in reported general payments places this provider in the 50th percentile of 2,087 family medicine providers in Tennessee.

See all family medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$41,266
Medicare patients
182
Services billed
692

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide144$188,285
EliquisApixaban92$99,094
Trelegy ElliptaFluticasone/Umeclidin/Vilanter70$75,833
LinzessLinaclotide47$69,579
JardianceEmpagliflozin33$51,280
TrulicityDulaglutide44$50,879
FarxigaDapagliflozin Propanediol29$34,647
RexultiBrexpiprazole23$30,928
MounjaroTirzepatide25$28,301
MyrbetriqMirabegron23$27,138
RybelsusSemaglutide11$22,371
JanumetSitagliptin Phos/Metformin Hcl13$20,940
XareltoRivaroxaban19$20,442
UbrelvyUbrogepant12$13,818
Breo ElliptaFluticasone/Vilanterol14$11,830

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$52$210,656155 claims
PfizerEliquis$12$99,09492 claims
GSKTrelegy Ellipta, Breo Ellipta$54$87,66384 claims
Otsuka America Pharmaceutical, Inc.Rexulti$44$30,92823 claims
Astellas Pharma US IncMyrbetriq$189$27,13823 claims
MerckJanumet, Belsomra$21$25,91224 claims
Johnson & JohnsonXarelto$32$20,44219 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 2,087 family medicine providers in Tennessee.

Other family medicine in Nashville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →